Hyloris Pharmaceuticals Investor Relations Material
Latest events
Investor Presentation
29 Mar, 2025
H2 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hyloris Pharmaceuticals SA
Access all reports
Hyloris Pharmaceuticals SA is a Belgian specialty pharmaceutical company that develops reformulated and repurposed medicines. Its portfolio focuses on improving existing drugs to address unmet clinical needs across hospital and emergency care settings. The company engages in regulatory development and commercialization through partnerships. It is headquartered in Liège, Belgium, and its shares are listed on the EURONEXT Brussels.
Key slides for Hyloris Pharmaceuticals SA
Investor Presentation
Hyloris Pharmaceuticals SA
Investor Presentation
Hyloris Pharmaceuticals SA
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
HYL
Country
🇧🇪 Belgium